Skip to main content
Journal of the Canadian Association of Gastroenterology logoLink to Journal of the Canadian Association of Gastroenterology
. 2019 Mar 15;2(Suppl 2):545–547. doi: 10.1093/jcag/gwz006.275

A276 CLINCAL PREDICTORS FOR SESSILE SERRATED ADENOMA DETECTION: AN ANALYSIS OF 17,524 COLONOSCOPIES

M Gandhi 1, S Cocco 2, C McDonald 1, Z Hindi 3, D Chakraborty 3, K French 4, O Siddiqi 5, M Blier 3, B Markandey 3, V Siebring 6, M Brahmania 1, N Khanna 1, V Jairath 1, B Yan 1, M Sey 1
PMCID: PMC6512487

Abstract

Background

Adenoma detection and removal is crucial to prevent colon cancer. Although adenoma detection rate is the current benchmark, there is increasing interest in sessile serrated adenoma detection rate (SSADR) given sessile serrated adenomas (SSAs) are more difficult to identify endoscopically.

Aims

To define predictors of SSA detection in a large colonoscopy cohort.

Methods

We performed a prospective observational study using colonoscopy quality metrics collected by Cancer Care Ontario. All colonoscopies performed for any indication across 20 hospitals in Southwestern Ontario between April 2017 and February 2018 were identified. Data collected included patient demographics, procedural indication, bowel preparation, cecal intubation, endoscopist information, and histology of polyps removed. Cases without histology records were excluded. A multi-variable analysis was conducted to identify factors associated with SSA detection.

Results

In total, 17,524 colonoscopies (mean (SD) age = 59.6 (14.4), 53.9% female) were identified. At least one SSA was identified in 910 procedures, corresponding to a SSADR of 5.2%. On multi-variable analysis, variables independently associated with higher SSADR included increasing patient age (OR 1.02, 95% CI 1.02–1.03, p<0.001), cecal intubation (OR 3.80, 95% CI 1.87–7.71, p<0.001), use of split dose bowel preparation (OR 1.33, 95% CI 1.00–1.77, p=0.047), and very good bowel preparation quality (OR 2.48, 95% CI 1.38–4.44, p=0.002). Factors associated with lower SSADRs included non-screening colonoscopies (OR 0.55, 95% CI 0.48–0.63, p<0.001) and non-gastroenterologist endoscopist (general surgery OR 0.50, 95% CI 0.41–0.60, p<0.001; internal medicine OR 0.70, 95% CI 0.51–0.96, p=0.027; general practice OR 0.20, 95% CI 0.06–0.68, p=0.010).

Conclusions

Modifiable factors associated with higher SSADRs include use of split dose bowel preparation, better bowel preparation quality, cecal intubation, and specialty of endoscopist. Ongoing initiatives emphasizing the importance of these variables should be encouraged.

Clinical Predictors for SSA Detection

Total (n=17,524) Presence of SSA (n=910) Absence of SSA (n=16,614) p-value
Age-mean (SD) 59.6 (14.4) 63.4 (11.8) 59.4 (14.5) <0.0001
Sex-no. (%)
Female 9,451 (53.9%) 493 (5.2%) 8,958 (94.8%) 0.882
Male 8,071 (46.1%) 417 (5.2%) 7,654 (94.8%)
ASA grade-no. (%)
1 5,168 (29.5%) 241 (4.7%) 4,927 (95.3%) 0.833
2 8,559 (48.8%) 507 (5.9%) 8,052 (94.1%)
3 3,540 (20.2%) 151 (4.3%) 3,389 (95.7%)
4 252 (1.4%) 11 (4.4%) 241 (95.6%)
5 4 (0.02%) 0 (0%) 4 (100%)
Indication-no. (%) <0.001
Screening/Surveillance 7,265 (41.5%) 487 (6.7%) 6,778 (93.3%)
FOBT+ 732 (4.2%) 48 (6.6%) 684 (93.4%)
Symptomatic 9,526 (54.4%) 375 (3.9%) 9,151 (96.1%)
Admission status-no. (%) 0.074
Outpatient 16,826 (96.0%) 884 (5.3%) 15,942 (94.7%)
Inpatient 698 (4.0%) 26 (3.7%) 672 (96.3%)
Bowel prep timing-no. (%) 0.001
Split dose 15,683 (90.0%) 844 (5.4%) 14,839 (94.6%)
Non-split dose 1,746 (10.0%) 60 (3.4%) 1,686 (96.6%)
Complete colonoscopy-no. (%) <0.001
Cecal intubation 16,627 (96.3%) 896 (5.4%) 15,731 (94.6%)
No cecal intubation 635 (3.7%) 8 (1.3%) 627 (98.7%)
Bowel prep quality-no. (%) <0.001
Very good 14,161 (80.9%) 773 (5.5%) 13,388 (94.5%)
Fair 2,734 (15.6%) 125 (4.6%) 2,609 (95.4%)
Poor 621 (3.6%) 12 (1.9%) 609 (98.1%)
Specialty <0.001
GI 7,739 (44.2%) 527 (6.8%) 7,212 (93.2%)
General surgery 8,350 (47.7%) 315 (3.8%) 8,035 (96.2%)
Internal medicine 1,200 (6.9%) 65 (5.4%) 1,135 (94.6%)
General practice 230 (1.3%) 3 (1.3%) 227 (98.7%)
Length of practice-median (IQR) 13 (6,27) 15 (6,20) 13 (6,27) 0.021
Procedure site-no. (%) <0.001
Academic centre 10,214 (58.3%) 637 (6.2%) 9,577 (93.8%)
Non-academic centre 7,310 (41.7%) 273 (3.7%) 7,037 (96.3%)
Trainee involvement-no. (%) 0.202
Present 3,507 (20.1%) 168 (4.8%) 3,339 (95.2%)
Absent 13,910 (79.9%) 741 (5.3%) 13,169 (94.7%)

Funding Agencies

None


Articles from Journal of the Canadian Association of Gastroenterology are provided here courtesy of Oxford University Press

RESOURCES